Related Experiment Video
Updated: Jun 21, 2026
09:51
The Transition to an Anterior-Based Muscle Sparing Approach Improves Early Postoperative Function but is Associated with a Learning Curve
Published on: September 7, 2022
Hip resurfacing arthroplasty for ankylosing spondylitis
1Department of Orthopedics, Changhai Hospital Affiliated to the Second Military Medical University, Shanghai, China.
The Journal of Arthroplasty
|August 18, 2009
Summary
Hip resurfacing offers better range of motion improvement than total hip arthroplasty (THA) with similar pain relief. This makes it a viable option for young ankylosing spondylitis (AS) patients.
Area of Science:
- Orthopedic Surgery
- Biomaterials Science
Background:
- Total hip arthroplasty (THA) is a common procedure for hip joint issues.
- Hip resurfacing is an alternative surgical option.
- Ankylosing spondylitis (AS) patients require joint mobility to prevent re-fusion.
Purpose of the Study:
- To compare the clinical outcomes of metal-on-metal hip resurfacing versus ceramic-on-ceramic total hip arthroplasty (THA).
- To evaluate the range of motion (ROM) and pain relief in both surgical groups.
- To assess the suitability of hip resurfacing for young ankylosing spondylitis (AS) patients.
Main Methods:
- Comparative study of two patient groups: metal-on-metal hip resurfacing and ceramic-on-ceramic THA.
- Recording and analysis of preoperative and postoperative range of motion (ROM).
- Assessment of clinical outcomes using the Harris hip score.
Main Results:
- Both hip resurfacing and THA groups showed satisfactory clinical and radiographic results.
- No significant difference in Harris hip scores between the two groups.
- Hip resurfacing group demonstrated a significantly wider range of motion (ROM) compared to the THA group (P < .01).
Conclusions:
- Hip resurfacing provides superior ROM improvement over THA, with comparable pain relief.
- The high stability and low dislocation rate of hip resurfacing facilitate early functional exercises.
- Hip resurfacing presents a reasonable alternative for younger ankylosing spondylitis (AS) patients, aiding in the prevention of re-ankylosis.
